Question 1

What is the catalog number for Mesotrypsin IN-1?

Accepted Answer

The catalog number for Mesotrypsin IN-1 is orb3135818.

Question 2

What sizes are available for Mesotrypsin IN-1?

Accepted Answer

Mesotrypsin IN-1 is available in the following size(s): 50 mg, 10 mg.

Question 3

How many pack sizes does Mesotrypsin IN-1 come in?

Accepted Answer

Mesotrypsin IN-1 is available in 2 different pack sizes.

Question 4

Is Mesotrypsin IN-1 in stock?

Accepted Answer

Mesotrypsin IN-1 is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What is Mesotrypsin IN-1 used for?

Accepted Answer

Mesotrypsin IN-1 (Compound CP13) is a selective inhibitor of Mesotrypsin, with an IC50 value of 134.6 μM. It is utilized in research focusing on cancers such as breast cancer, colon cancer, and pancreatic cancer.

Question 6

What is the difference between this product and a similar catalogue number?

Accepted Answer

Differences typically involve clone, conjugate, host species, or validated applications. Compare the respective datasheets, or contact us with both catalogue numbers for a direct comparison.

Question 7

Do you offer custom or private-label production of this type of product?

Accepted Answer

Yes, custom antibody development and private-label production services are available. Contact our sales team to discuss your target, timeline, and quantity requirements.

Question 8

What is the immunogen used to generate this antibody?

Accepted Answer

Immunogen or antigen details used to raise this antibody are listed on the product datasheet under immunogen information.

Mesotrypsin IN-1

Product Specifications

CAS Number

Smiles

Molecular Formula

Molecular Weight

Storage Conditions

Notes

Available Sizes

Frequently Asked Questions

Explore Other Products

Liver Canuliculi (HSA98), CF640R conjugate, 0.1mg/mL

Frozen Tissue Sections, Colon

Tissue FFPE Sections, Prostate

MT1H (NM_005951) Human Over-expression Lysate

Advantame-D3

Mouse Cxcr3 activation kit by CRISPRa